Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
American College of Rheumatology (ACR) (Lupus can be life-threatening if left untreated. #lupus http://t.co/PCEZj7heE7) 
No comment yet.
Sign up to comment
Scoop.it!
Rheumatology Medical Article: IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy (ILいまいくつあんの？RT @MDLinx: IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy: Human Immunology
Scoop.it!
Anti-Th/To autoantibodies have been recognized as serological markers of systemic sclerosis (SSc) for more than 20 years. However, validated immunoassay kits to test this specificity have not been commercially available.
Scoop.it!
Knee osteoarthritis (kOA) risk is increased by obesity and physical activities (PA) which mechanically stress the joint.
Scoop.it!
American College of Rheumatology (ACR) (RT @ACRheum: Have you seen our patient fact sheet on living well w/ a #rheumatic disease?
Scoop.it!
Dr. Battafarano Clinicians often fear social media and perceive it to be only Facebook, Twitter, and YouTube. Via Alan Horton
Scoop.it!
OBJECTIVES: To explore the effectiveness and safety of hyaluronic acid (HA) administration for ankle osteoarthritis (OA), and to investigate the effects of variations in HA regimens on treatment responses. Via sportEX
Scoop.it!
Galapagos Wins $4M Milestone Payment in Servier Osteoarthritis Alliance Genetic Engineering News Galapagos said today it received a €3 million (about $4 million) milestone payment from Servier tied to the late-stage discovery of new small molecules...
Scoop.it!
FDA approves infusible golimumab for treatment of RA patients
Scoop.it!
(Credit: KayVee.INC/Flickr). JOHNS HOPKINS (US) — Osteoarthritis, a painful disease thought to be primarily a problem with the cartilage that cushions joints, may actually be caused in large part by the bone underneath.
Scoop.it!
'US News & World Report' ranks Johns Hopkins best hospital for rheumatology
Scoop.it!
Wayne Channon's curator insight,
July 14, 2013 9:17 AM
Umbilical cord blood stem cells could be the future of regenerative medicine.
Scoop.it!
From BioPortfolio: Encouraging data from preclinical studies, and ongoing clinical trials, suggest that mesenchymal stem cells (MSCs) might provide the disease-modifying therapy t...
|
Scoop.it!
An approval of US drug major Eli Lilly (NYSE: LLY) and Incyte Pharmaceuticals'(Nasdaq: INCY) drug baricitinib is predicted to prove paramount to the autoimmune community, but the recent rise of biosimilars threatens the long-term future of pharma...
Scoop.it!
Rhianna Lindop, Georgia Arentz, Isabell Bastian, Andrew F. Whyte, Lauren A. Thurgood, Tim K. Chataway, Michael W. Jackson, Tom P....
Scoop.it!
Transition Therapeutics is in-licensing TT-601, Eli Lilly's small molecule transcriptional regulator for the treatment of osteoarthritis pain.
Scoop.it!
ISTO's Cell Therapies Can Revolutionize Treatment of Joint, Bone Injuries OneMedPlace (blog) ISTO's Cell Therapies Can Revolutionize Treatment of Joint, Bone Injuries · 1756, bone regeneration, cartilage, cartilage regeneration, knee repair,...
Scoop.it!
Anti-TNF therapy feasible in patients with infection
Scoop.it!
Overall, knee osteoarthritis may affect more than 250 million people and is a leading contributor to disability worldwide. Via sportEX
Scoop.it!
A Georgia spinoff of Carticept Medical is testing a synthetic cartilage implant made with a biomaterial designed to mimic the qualities of cartilage.
Scoop.it!
The co-existence of high prevalence of vitamin D inadequacy among Canadians and high prevalence of systematic autoimmune rheumatic diseases (SARDs) raise the question on relationship between the two situations.
Scoop.it!
The limited availability of pediatric rheumatologists for teaching in pediatric residency programs negatively impacts resident education about rheumatology. At present, there are no educational websites available for trainees ...
Scoop.it!
Fundamentals of Rheumatology Course was created to meet the specific needs of those transitioning into rheumatology practice such as nurses, office nurses, licensed practical nurses (LPN), medical assistants (MA) and office managers, staff or other clinicians that could benefit from one easy-to-access online resource that offers a current evidence-based comprehensive overview of the rheumatologic disorders and insurance preauthorization.
A course at American College of Rheumatology: http://www.rheumatology.org/index.asp
See also, The Rheumatology Research Foundation: http://www.rheumatology.org/foundation/about.asp#src=social
Via Alfredo Corell
Scoop.it!
A blockbuster drug made by Amgen is no more effective than a cocktail of cheaper generic therapies in treating a severe joint disease affecting an estimated 1.3 million Americans, according to a new study funded by the Department of Veterans Affairs. Via Richard Meyer
Richard Meyer's curator insight,
June 12, 2013 7:13 AM
The findings could prompt changes in the way physicians treat patients, potentially saving significant amounts of money, although some researchers suggested that current treatments may be too well entrenched to be dislodged. Amgen's Enbrel, which had global sales of $4.23 billion last year, and similar biologic drugs are often prescribed to treat rheumatoid arthritis after patients have failed to respond to a generic drug called methotrexate, which is the most commonly used front-line therapy.
Scoop.it!
(Reuters) - Roche Holding AG said U.S.regulators have widened the approved use of rheumatoid arthritis drug Actemra to include patients typically in earlier stages of treatment for the joint disease.Actemra... Via Richard Meyer
|
